Podcast appearances and mentions of sarah maxwell

Explore why conscious leadership isn't just a trend—it's a necessity, as told by Sarah Maxwell.

“Fidelity Tool” Helps Pediatric Physical Therapists Implement Guidelines for Patients with Cerebral Palsy Findings from a study looking at a method of ensuring physical therapists can more easily implement evidence-based guideline therapy for children with cerebral palsy has been published in Pediatric Physical Therapy journal. First author Michelle Jackman PhD, Occupational Therapist & Research Fellow, at the Cerebral Palsy Research Institute of University of Sydney, Australia and the CP Alliance Research Foundation in Newcastle, New South Wales, Australia has been discussing her group's findings in the latest edition of the Pediatric Physical Therapy podcast with correspondent Sarah Maxwell, in the company of Editor-in-Chief, Linda Fetters PhD PT FAPTA, University of Southern California, Los Angeles, USA. JOURNAL TITLE: Implementing Clinical Practice Guidelines for improving function in Cerebral Palsy: Development of a Fidelity Tool

Hi Friends! Final episode from our first visit to Brooklin Boat Yard: a tour of the winter storage sheds where so many cool boats gather for their long winter's nap. John and Sarah Maxwell take us through a collection of saling and motor yachts big and small, old and new. We go through two big barns, you'll hear the gravel floor crunching under our feet as John tells us the story of classic sailing yachts and restored lobster boats. We climb aboard two stunning fifty foot motor yachts, including SYNTAX, launched by BBY just this past summer.  Steph will rejoin soon, in the meantime hope you enjoy this format!  Thank you so much for listening!

The Pediatric Physical Therapy Podcast, September, 2024 This special edition of the Pediatric Physical Therapy podcast is reviewed by Pediatric Pediatric Physical Therapy Journal Editor-in-Chief, Linda Fetters PhD PT FAPTA, University of Southern California, Los Angeles. This podcast examines the 2024 Updated Evidence-Based Clinical Practice Guideline on the Physical Therapy Management of Congenital Muscular Torticollis. Podcast host Sarah Maxwell is joined by first author of the Updated Guideline, Dr. Barbara Sargent and clinician author, Dr. Jill Cannoy PT, DPT, PCS. Podcast Speakers: JILL CANNOY PT, DPT, PCS, Orthotics and Prosthetics Department, Children's Healthcare of Atlanta, Atlanta, Georgia. BARBARA SARGENT PhD, PT, Associate Professor of Physical Therapy, University of Southern California Journal Abstract: Physical Therapy Management of Congenital Muscular Torticollis: A 2024 Evidence-Based Clinical Practice Guideline From the American Physical Therapy Association Academy of Pediatric Physical Therapy Barbara Sargent, PT, PhD, PCS; Colleen Coulter, PT, DPT, PhD, PCS; Jill Cannoy, PT, DPT, PCS; Sandra L. Kaplan, PT, DPT, PhD, FAPTA Division of Biokinesiology and Physical Therapy, Herman Ostrow School of Dentistry, University of Southern California (Dr Sargent), Los Angeles, California; Orthotics and Prosthetics Department (Drs Coulter and Cannoy), Children's Healthcare of Atlanta, Atlanta, Georgia; Department of Rehabilitation and Movement Sciences, Rutgers (Dr Kaplan), The State University of New Jersey, Newark, New Jersey Background: Congenital muscular torticollis (CMT) is a postural condition evident shortly after birth. The 2013 CMT Clinical Practice Guideline (2013 CMT CPG) set standards for the identification, referral, and physical therapy management of infants with CMT, and its implementation resulted in improved clinical outcomes. It was updated in 2018 to reflect current evidence and 7 resources were developed to support implementation. Purpose: This 2024 CMT CPG is intended as a reference document to guide physical therapists, families, health care professionals, educators, and researchers to improve clinical outcomes and health services for children with CMT, as well as to inform the need for continued research. Results/Conclusions: The 2024 CMT CPG addresses: education for prevention, screening, examination and evaluation including recommended outcome measures, consultation with and referral to other health care providers, classification and prognosis, first- choice and evidence-informed supplemental interventions, discontinuation from direct intervention, reassessment and discharge, implementation and compliance recommendations, and research recommendations. (Pediatr Phys Ther 2024;00:1–45)Key words: clinical practice guideline, congenital muscular torticollis, infant, pediatrics, physical therapy

Pediatric Physical Therapy Podcast Volume 36, Issue 3, 2024 Creator: Pediatric Physical Therapy AN INTERVIEW WITH: Toby Long PhD, Department of Pediatrics, Center for Child and Human Development, Georgetown University, Washington DC, USA. “Inclusion, Participation, Belonging = Surviving, Thriving, Flourishing” Toby Long PhD tells podcast anchor Sarah Maxwell about the role physical therapists play in helping children with impairments participate in day-to-day life: the theme she addressed in her lecture to the Academy of Pediatric Physical Therapy for the prestigious Ann Van Sant Global Scientific Writing Lectureship, now documented in her Pediatric Physical Therapy article. Title: Inclusion, Participation, Belonging = Surviving, Thriving, Flourishing Author: Toby Long, PT, PhD, FAPTA Author affiliations: Department of Pediatrics, Center for Child and Human Development, Georgetown University, Washington, DC, USA Conflict of Interest Statement: The author declares no conflict of interest. Correspondence: Toby Long, 2115 Wisconsin Avenue, NW, Suite 600, Washington, DC 20007. Email: longt@georgetown.edu ABSTRACT Purpose: To share my perspectives on how pediatric physical therapists support children with disabilities and their families to maximize their potential to flourish. Key Points: Best practice supports the inclusion of people with disabilities in all aspects of society. Policy statements from governmental agencies, research universities, advocacy, and non- governmental organizations all support inclusion. The concept of belonging and how pediatric physical therapists can promote belonging is less familiar to pediatric physical therapists than that promote belonging. Key words: International perspectives, inclusion, participation, belonging inclusion and participation.

Welcome to the Season Opener for Season 2 of Inside Design. In this episode, Sarah Maxwell chats with Jane Ledger about the second part of her journey in design from Sydney to Perth. This time the story takes us inside a smoky nightclub and what happens after she meets a mysterious man on the dancefloor. But it's what happens decades later that is the greatest surprise of this story. As you listen, Jane shares how throwing away the 'shoulds' of her life and moving beyond the expectations and views of others, has taken her design, and personal, journey to a whole new level. If you loved the beginning of this story last season (https://podcasts.apple.com/au/podcast/inside-design/id1700365558?i=1000622994947), then you are going to love this chapter that shows us the most important thing you can do in life is to just be you and do what you truly love.Connect with us: Website https://janeledger.com.au Instagram https://www.instagram.com/janeledgerinteriors Thank you for listening! If you found this useful, please leave a like, review or rating as this helps other people just like you find this information. I'd love for you to hit follow wherever you're listening to this and share a favourite episode with someone you know who would really benefit from it.

'Give us a break!' say surfing farmers, a back country dream comes true on horseback, Sarah Maxwell's farming journey and a wrap of the week's rural news.

Sarah Maxwell goes from inseminating cows in the morning to shifting cows and sheep in the afternoon, working at the local sale yards and more besides.

Welcome to Inside Design! Meet our host, Jane Ledger, a powerhouse in the interior design industry. With a diverse background in law, marketing and HR, Jane's journey led her to follow her creative passion. She achieved High Commendation at the International School of Colour & Design, marking a new chapter in her life. As the founder of Jane Ledger Interiors, she has built a loyal client base specialising in high-end residential interiors. Jane is known as a leading voice in the industry and an advocate for Australian design and the design profession as a whole.Her exceptional expertise and fresh perspective will inspire you as we explore her fascinating journey and uncover the driving forces behind her success. In this conversation, Chatta-Box Media's Sarah Maxwell and Jane discuss:How Jane's prior skills in law, marketing and management complemented her path to interior design.Jane shares her life's personal  journey thus far and how those experiences have shaped who she is today personally and professionally. Future Inside Design podcasts are explored, highlighting the guests and subjects that will be covered through the series.Jane shares her dream outcome for the podcast and describes the impact she hopes to achieve through the show.Connect with us: Website https://janeledger.com.au Instagram https://www.instagram.com/janeledgerinteriors Thank you for listening! If you found this useful, please leave a like, review or rating as this helps other people just like you find this information. I'd love for you to hit follow wherever you're listening to this and share a favourite episode with someone you know who would really benefit from it.

Sarah Maxwell and Mr A+ were dating for a short time but now the pair are good friends. On this weeks episode Mr A+ and Sarah chat about eating disorders and about Sarah's many years battling anorexia. They recorded this chat in the hope that it will help others who are also struggling and to bring awareness about this terrible disease. Follow Mr A+ on Instagram and DM him here Podcast inquiries: MrAPlusPodcast@gmail.com Follow Sarah on Instagram here and email her here For help with an eating disorder in Australia contact Butterfly Foundation or call the national helpline on 1800 33 4673See omnystudio.com/listener for privacy information.

Sarah Maxwell and Mr A+ were dating for a short time but now the pair are good friends. On this weeks episode Mr A+ and Sarah chat about eating disorders and about Sarah's many years battling anorexia. They recorded this chat in the hope that it will help others who are also struggling and to bring awareness about this terrible disease. Follow Mr A+ on Instagram and DM him here Podcast inquiries: MrAPlusPodcast@gmail.com Follow Sarah on Instagram here and email her here For help with an eating disorder in Australia contact Butterfly Foundation or call the national helpline on 1800 33 4673See omnystudio.com/listener for privacy information.

Hey, guys, welcome to another episode of Spilling the Beans. Today I'm sitting down with Sarah Maxwell. She's been our Director of Operations and Director of Membership for the Legacy Family Mastermind for the past two and a half years, and this Friday was her last day working with us. It's super sad, but kind of bittersweet because she's taking the things that she's learned from the mastermind -- the connections, the insights, the relationships -- and applying them to her own entrepreneurial journey. So as much as we hate to see her go, we are super excited for her next chapter in life. I'm excited to sit down with her to talk about her transition and how hanging out with entrepreneurs has helped her to discover her own superpowers. //SAY HI TO SARAH Instagram: @sarah.a.maxwell Facebook: https://www.facebook.com/profile.php?id=100014055580616 Maxwell Creative Contracting: https://www.instagram.com/maxwell_creative_contracting/ Metts BBQ Sauce: https://www.mettsbbqsauce.com 0:00 Meet Sarah 5:36 The Power of Masterminds 10:07 Learning Your Superpowers 16:04 Working with Your Husband 19:50 Doing What You Say You're Gonna Do 23:10 Sarah's New Role 28:45 Metts BBQ Sauce 34:07 Helping Each Other Succeed //LINKS TO MY OFFERS Legacy Wealth Academy: https://www.lwacademy.com/ Commercial Empire: http://commercialempire.com/ Legacy Family Mastermind: http://legacyfamilymastermind.com/ Click here to download our FREE multifamily deal calculator: http://legacywealthholdings.ac-page.com/calculator-giveaway //FOLLOW ME ON SOCIAL IG - https://www.instagram.com/timbratz/​ TikTok - https://www.tiktok.com/@timbratz Facebook - https://www.facebook.com/tlbratz​ LinkedIn - https://www.linkedin.com/in/timbratz/​ Website: LegacyWealthHoldings.com //ABOUT ME Tim Bratz is the Founder & CEO of Legacy Wealth Holdings, a leading real estate investment company. He focuses on vision-casting, marketing, & supporting his team of “A” players. He has built his company on integrity (doing what he said he was going to do), fairness (doing the right thing), & transparency (honesty is always the best policy). Tim has dedicated his professional life to studying wealth-building & personal finance. Working in real estate, Tim has learned how to create a passive income that allows him to live the lifestyle of his choice. His goal is to educate & empower others to become financially free through entrepreneurship & real estate investments. https://legacywealthholdings.com // WANT A MORE IN-DEPTH LOOK AT REAL ESTATE INVESTING? Check us out! https://linktr.ee/timbratz

Join us in our latest podcast episode as we delve into the extraordinary world of Sarah Maxwell Beauty, showcasing the best in eyelash and eyebrow products. With years of experience under her belt, Sarah has mastered the art of creating stunning, eye-catching looks. Listen in as we discuss her journey, her expertise, and her dedication to delivering the highest quality products. Plus, get an exclusive first look into her upcoming fragrance line that's set to revolutionize the world of scents. Don't miss this captivating conversation with the trailblazing beauty mogul, Sarah Maxwell --- Send in a voice message: https://podcasters.spotify.com/pod/show/skincareanarchy/message Support this podcast: https://podcasters.spotify.com/pod/show/skincareanarchy/support

Sarah Maxwell is currently holds the title of Miss Veteran's Day New Jersey 2023 and an adult living with clubfoot. I first heard Sarah's story through social media and was inspired by her story and the way she spreads awareness of clubfoot. In this episode, Sarah talks about experience participating in the Miss America sponsorship competitions, how her clubfoot has impacted her journey, and how she uses her social impact initiative to spread clubfoot awareness. I am excited for you all to hear her story and a huge thank you to Sarah for her willingness to share and for all she does to support the clubfoot community,

Hailing from frosty Canada, Sarah Maxwell became a Beach Volleyball Player representing Canada for 9 years. Moving to Australia with her team in 2000, she was coached by the world's best and improved her ranking into the Top 10 worldwide. She also ended up marrying Australian 5-time Olympian and Gold Medallist Natalie Cook and they have a beautiful 4 year old daughter. After retiring from sport, Sarah took her BioPsychology degree and married her curiosity for relationships becoming an NLP-Certified Trainer and coach. Sarah also host a podcast - “In The Game Podcast” includes more of the conversations shaping her world: including a Relationship Series in the lead up to her first book due out February 2023! Upon return from their epic Europe trip, Sarah developed a new program inviting transitioning Mothers to awaken their dormant dreams, named ‘The Awakened Mama' Follow Shivani on @askshivani Subscribe to make sure you hear all updates from her! https://www.askshivani.com/ Follow https://www.linkedin.com/in/askshivani/ Email her at shivani@askshivani.com

How Success Happened For Beauty Entrepreneur Sarah Maxwell, Founder of Sarah Maxwell Beauty—Lash expert, Sarah Maxwell, discovered her talent for beauty years ago working with some of Hollywood's elite talent perfecting their brows. Being in the service industry and excelling, she started to wonder, what's the next level I can take this to?From service industry to thriving beauty entrepreneur, listen in to Sarah's entrepreneurial journey that can help inspire you or answer your questions around scaling your services as a provider to a full-time successful business.Sarah's Mission: Two fold of solutions, result driven, easy to use products and empowering others to create their dream job too.About our guest, Sarah Maxwell:LA based lash expert and makeup artist Sarah Maxwell has forged a name for herself through her artistic subtlety, signature red carpet looks, and professionally trained eye. Sarah's work continuously graces film premieres, executive summits, and gala events — any occasion where her clients rely on her to look their very best. Founded in 2019, Sarah Maxwell Beauty was launched with the belief that her exclusive products and expert lash techniques — once available only to her personal clients — could be accessible to anyone.Website: sarahmaxwellbeauty.comIG: @sarahmaxwellbeauty—About the Host:Sara Quiriconi is an actress, artist, entrepreneur and creative storyteller, inspired and driven to empower others to be resilient, never settle, live well and live free.Podcast: Subscribe NEVER SETTLEWeb: LiveFreeWarrior.comInstagram: @livefreewarriorYouTube : Live Free WarriorCoaching: Warrior Mindset One-On-One

In this episode Millie chats to Sarah Maxwell. Sarah is a mental health physiotherapist, she is currently back at university studying a masters of counselling. They discuss her Anorexia recovery journey, the impact that receiving residential treatment in the USA has had on her recovery, the importance of a supported transition back into the community and the value of human connection and vulnerability.There is hope at ended.org.au endED is a nonprofit organisation and needs your support to continue providing guidance and hope for those affected by eating disorders. DONATE HEREFollow endED on Facebook or Instagram Follow Millie on Instagram Hosted on Acast. See acast.com/privacy for more information.

Sarah Maxwell is a good friend and fellow Mindset Coach, as well as one of Ryan's mentors. Sarah is originally from Swansea, UK and now lives in Gold Coast, Australia. She has worked in child services for many years as a youth case manager, and now runs her own coaching business, has her own blog and is an all-round incredible human being. In this podcast Ryan and Sarah discuss Achieving Balance, Personal Values, Self-Growth, Vision Boards, Dealing with Grief, Menstrual Cycles in relation to Motivation, as well as the Peaks and Troughs of life. Instagram: @SarahMaxwell.Blog

These Drum Majors defend the fact that BAND IS A SPORT! Hear what's got them to this point, the legacy they want to leave & what they have planned for the future. Pam Chambliss fills us in on the latest with FCA (what is a "Popsicle Blast?"). Our sports analyst, Greg Glasscock, gives us a recap of last week's local football games. We pick the next 6 big games in college football. And, Cameron Gipson guest co-hosts the show today. If you like what you hear, please subscribe & tell a friend. Thanks!

Denise Gregory, Lori Lourens, Isaac Piersma, and Sarah Maxwell with Union Street Players preview Mamma Mia, coming to the Pella Community Center this Thursday through August 8th. Find ticket purchasing details at the Union Street Players website.

Tyler sits down with Sarah Maxwell, Board Certified Music Therapist, to explore music therapy and all of its benefits. In so many ways, every one of us is organically a “patient” of music therapy. Sarah validates this notion, but proceeds to illuminate all of the many ways in which music is used in clinical and therapeutic modalities to change the way we see the world. In short, Sarah shows us how music heals us, without regard to the ailment.

This week Florence and Reed speak to Sarah Maxwell, an American comic artist and illustrator based in London, who uses her beautiful art to elevate the queer community. Her work ranges from fashion illustration to animated GIFs and comics, and she says her work is best summed up in 4 key words: nostalgia, tenderness, femininity, and 80’s electronic music.'F**ks Given' with Come Curious presents an honest and candid exploration of their guests’ sexual histories, from the first f**k to the best f**k and even the bad, average and comical ones in between. Each episode is an uncensored look at what’s gone on beneath the sheets with a variety of coveted guests in a bid to break the stigma around sexual histories and specifically the ‘number’ taboo. Presented by Come Curious, change-makers in the sex and body positivity space, 'F**ks Given' aims to open up the conversation around our sexual past, asking us to celebrate all the f**ks you gave because they’re the ones that made you who you are. You can follow Come Curious on Instagram / Twitter / Youtube This is a Studio71 production.Producer - Jack ClaramuntAssistant Producer - Winnie SimonExec Producer - Tom Payne & Jody SmithProduction Support - Phie McKenzie & Rebecca Dowell Studio71 is a Red Arrow Studios Company. See acast.com/privacy for privacy and opt-out information.

Tune in as we chat with lash, brow and beauty expert Sarah Maxwell today.  She's a mom, an entrepreneur and celebrity beauty favorite.  She's got a great story so check it out! @kiddontkillmyvibe

As a music therapist, Sarah Maxwell comforts the sick and dying. She shares what the dying have taught her about how to live, love and comfort yourself.

In this episode, we talk about a concerning security flaw in the Tesla Model X, and Twitter’s fleet rollout and subsequent rollback. Then we check back in with Sarah Maxwell, spokesperson for the Coalition on App Fairness, about Apple’s new reduced app store commission for certain developers. Finally, we chat with Kevin Miller, website lead at the COVID Tracking Project, about what has become one of the most trusted sources on the spread of the pandemic. Show Notes DevDiscuss (sponsor) Triplebyte (sponsor) CodeNewbie (sponsor) Vonage (sponsor) This Bluetooth Attack Can Steal a Tesla Model X in Minutes Fleets: a new way to join the conversation Apple announces App Store Small Business Program Coalition for App Fairness The COVID Tracking Project RubyConf Tracking COVID with Ruby

In this episode, we cover some updates about Ruby 3, OpenAI, and React 17's JSX Transform, and then a disconcerting data-sharing aspect from the exercise app, Strava. Then we chat with Alex Hanna, sociologist and research scientist working on machine learning fairness and ethical AI at Google, about Twitter’s algorithmic bias toward certain photos over others. And in light of all of the recent Apple app store battles with Epic Games, WordPress, and others, we speak with Sarah Maxwell, Coalition Spokesman for the Coalition for App Fairness, about the organization's efforts to make the app marketplace a more even playing field for developers. Show Notes DevDiscuss (sponsor) Triplebyte (sponsor) CodeNewbie (sponsor) Vonage (sponsor) Ruby 3 OpenAI Introducing the New JSX Transform Strava: The New Human-Powered Era Coalition for App Fairness

For many of us, when we got into beauty we dreamed of the day where Beyonce (or whoever your favorite celebrity is) would walk into your business and get lashes from you. To be able to serve high-end clients and charge top dollar is something we all hope to achieve one day. Today Sarah Maxwell, owner of Sarah Maxwell Beauty, joins us and gives us a peek of what it's like to serve an exclusive clientele. Sarah has been doing lashes since 2008 and has built a business serving clients most lash artists dream of having. In this episode, we talk about how high-end clients generally want a subtle look and not the volume look we all see on Instagram. Yes, volume has a place in this world, but if you want to attract a more refined customer, learning the art of subtlety is a must-have skill. She also discusses why she's okay doing lash fills on other lash artists' work, how she struggled with boundaries with clients wanting to be friends and not giving in to the pressure to open up a lash salon. We could have gone on for two hours with Sarah...lot's of great content. I'm sure you'll enjoy hearing from Sarah and how she built her business. After you listen to the episode, please share your thoughts on our IG page. https://www.sarahmaxwellbeauty.com/ IG: @sarahmaxwellbeauty GUEST ANNOUNCER: Janet Richardson @janet_richardson_artistry ANNOUNCEMENTS: SIGN UP FOR OUR NEXT CLASS! How To Get More New Clients Than Ever in Your Door DATE: August 24, 2020 TIME: 4pm-7pm (PST) Please Note: A replay of the webinar will be available for 2 weeks to everyone who buys a ticket. Click on the link to get your ticket: https://bit.ly/39EF7nj Has your business bounced back to where it was pre-Covid-19? If you're like most businesses, you've seen things slow down at least a little if not a lot. It's a difficult time to build a business to say the least. We opened our salon back in 2006, and then the Great Recession hit us in 2008. Our timing was horrible. On top of a slowed-down economy, most people didn't even know what lash extensions were and there was no Instagram to help us to affordably market our business (yes we lived in the stone ages). While it wasn't easy, we found a way to grow our business in the midst of the recession. Even though the cards were stacked against us, we grew our little salon and even hired our first staff during the recession. We tried all sorts of ways to promote the salon...some worked well and others...not so well. In this webinar, we will break down and share all the marketing tricks and promotions that worked and got our salon to grow into being a 7-digit award-winning in Southern California. When you are done, you'll be equipped with many new strategies and ideas that you can implement in your business. BTW...most of them have nothing to do with Instagram. WE WANT TO ANSWER YOUR QUESTIONS ON THE PODCAST If you have a question and you want us to answer it, please email it to paul@integritylash.com or DM us at @lashcastpodcast. We will try to answer one question during each episode so please send us your questions. BTW...you can ask us about pretty much anything...lashes, customer service, business, life...it's your call. GUEST ANNOUNCER LASCAST OPENING SCRIPT Here is our script that you can use to record the opening to our show: "Hi I’m (name) and I work at (name of biz) in (city, state) and I’m today’s guest announcer. You can find me on Instagram at (IG handle)! Cue the music… In an industry where most of us spend the majority of our time working alone in a room, this podcast was created so you can learn, be encouraged and find a connection with other lash and beauty professionals. This is the LashCast Podcast and here’s your host, Paul Luebbers." PLEASE FOLLOW US! IG: @lashcastpodcast @thelashconference.con Facebook: www.facebook.com/groups/lashcastpodcast/ Contact Paul Luebbers: paul@lashcastpodcast.com

Sarah is a Youth Case Manager, Blogger & worldly wanderer who joined Ryan over a Zoom Call to discuss The Law of Attraction, Chasing your Dreams & having unrelenting positivity.

#17: Last week I talked about how I treat miles and points as a tax-free asset class in my portfolio.That’s because they literally translate into thousands of bucks in savings. For every trip.It’s one of the highest impact ways to boost your nest egg because those dollars stay compounding in your portfolio rather than getting spent.That’s why for this week’s podcast, I invited Sarah Page Maxwell, a miles and points expert, to share strategies on how to maximize point redemptions specifically for free flights – especially international flights, since those have the biggest arbitrage opportunities for outsized redemption value.Whether you’re booking long-haul economy or splurging for business class, today’s episode will train you to think strategically about award travel so you save big on your future trips…and boost your nest egg at the same time!What you’ll learn in this episode:How the miles and points landscape has changed over the years and where the opportunities still areStrategies for maximizing your point redemptionsWhat is considered a “good” redemption value (and why you shouldn’t just use the sticker price of a flight)How to pick the flexible point program that best matches your travel goalsTradeoffs for redeeming from an issuer’s own travel portal vs. transferring out to partnersTools for getting the latest scuttlebutt on redemption arbitrage opportunities/inefficienciesLinks mentioned in this episode:MileValueMilez.bizPointsBuzzCredit card churning subredditFlyerTalkAfter our interview, Sarah also shared this resource: Where to credit. Tool to help you figure out where to best credit miles you earn when you fly. From Sarah: “Many don’t realize that just because you’re flying American doesn’t mean you have to credit the miles you earn to American. Credit them instead to a foreign frequent flyer program that hasn’t shifted to a revenue-based earning structure, but instead still awards miles based on distance flown. Simply put in what airline you’re flying and in what class, and it tells you how many miles you’d earning crediting to all the different partners.”HYW private Facebook communityIntro/Outro: Old Bossa by Twin Musicom.

Sponsored by Enneagram.LifeContact Sarah Maxwell about Enneagram Coaching at yourenneagramlife@gmail.com-Type 4s-Type 4 misconception -Healthy look at the Enneagram -Integration and Disintegration -Super Powers

We’re back with Part 2 of the Shared Care Special, where we’re following Sarah and Peter on the journey of their parental leave. Sarah Maxwell, People & Performance Director at Solotel, and husband, Peter, are sharing the parental leave with their newborn baby girl. The couple are alternating their blocks of leave, with Sarah having just returned to work after her first block of leave, handing over to Peter for his first block. In this Episode, Sarah shares why she found her transition back to work relatively smooth, and she is excited and looking forward to second next block of parental leave which is only a few weeks away now. What makes this series so unique is that we're following Sarah & Peter over a number of months, and hearing first-hand about how they're finding the experience. It's fantastic to see parental leave equality in action from the parent point of view.

-Characteristics of Type 4-The Emotions-Relationships-Integration and Disintegration-The beautiful aspects of Type 4Special thanks to Braeden Fraze, Libby Kirkpatrick, Nolan Weaver, Jay Lokey, Hannah Lindsey, and Sarah Maxwell. Referenced in Episode:The Road Back to You: Ian Cron and Suzanne Stabile

In this Shared Care Special, Sarah Maxwell, People & Performance Director at Solotel, opens up to us about how she and her husband plan to take their parental leave with their baby on the way. Their plan is to alternate in taking blocks of time off, with Sarah taking a block of 6-8 weeks off, then Peter taking 6-8 weeks, then Sarah will take a second block, then Peter will take a second block – up until 6-8 months when they will put their baby in care and both return to work. They both love their work, and are both passionate about being fully committed, hands-on parents, sharing the care for their child. What makes this series so unique is that we'll be able to follow Sarah & Peter over the coming months, and hear first-hand about how they're finding the experience. It's fantastic to see parental leave equality in action from the parent point of view.

Join us for #IndieMusicLIVE! 129 - Get the latest in #IndieMusic news and listen to the best #IndieMusicians we have found in the past week! Featured Artist: Sarah Maxwell Panel Guest: Andrea Desmond Music: Sarah Maxwell - "Flawed" Andrea Desmond - "The Strongest" mrs smith - "All I Do Is Cry" Reichelt - "Seduced By The Light Side" Shirina Music - "Wild" South Village - "Say It Now" Promote your music NOW: http://www.indiemusicplus.ecwid.com/ Hosted by JoeJoeKeys & David Werba Produced by Robert Hix of Hixvideo Submit your music for consideration at http://www.indiemusicplus.com/

Join us for #IndieMusicLIVE! 123 - Get the latest in #IndieMusic news and listen to the best #IndieMusicians we have found in the past week! Featured Artist: Blood of Angels Panel Guest: PThe Politician Music: Blood of Angels - TBA 9fm - "Allow Me" Lydmusik - "Alone In The Dark" Purkinje - "In The Sun" Sarah Maxwell - "Flawed" Promote your music NOW: http://www.indiemusicplus.ecwid.com/ Hosted by JoeJoeKeys & David Werba Produced by Robert Hix of Hixvideo Submit your music for consideration at http://www.indiemusicplus.com/

Sarah Maxwell is an Australian rapper, singer, songwriter and dancer. She is a powerhouse performer and is making waves in Sydney.     Social Media Links   https://www.instagram.com/sarahlouisemaxwell/   https://www.facebook.com/musicbymaxwell/

ATLANTA—Efficacy of the RTS,S malaria vaccine for children — vaccinated between six and 12 weeks age — checked-in at around 30 per cent in preliminary findings from Africa released at the American Society of Tropical Medicine and Hygiene conference by Dr John Lusingu of Tanzania’s National Institute of Medical Research. He told Sarah Maxwell that although this figure is lower than was hoped the data mean that a third of all cases of malaria are prevented among vaccinated children. Professor Sir Brian Greenwood of the London School of Hygiene & Tropical Medicine added his comment.

LONDON—One in twenty deaths in English hospitals could be prevented according to research published in the British Medical Journal Quality and Safety. Dr Helen Hogan of the London School of Hygiene & Tropical Medicine and her colleagues studied the causes of preventable deaths in English hospitals during the year 2009 and estimate that 12 000 preventable deaths occur each year. She discussed the findings and their implications with Sarah Maxwell.

The experience of pilgrims going to Mecca can help prepare London to host a healthy Olympic Games, according to Dr Ahmad Moolla the London medic and researcher who organised a special expert panel discussion on Mass Gatherings Medicine at the London School of Hygiene & Tropical Medicine. He gave Sarah Maxwell his views on what the experts had to say and how London 2012 is benefiting.

LONDON—Top medical experts met at the London School of Hygiene & Tropical Medicine for an “expert panel discussion” on mass gatherings medicine — which assessed the state of knowledge about managing the health of millions of people in London during the Olympic Games. Professor David Heyman, who chaired the meeting, gave Sarah Maxwell his assessment of the main issues.

LONDON—Britain’s Health Protection Agency has been planning to make sure everybody enjoys good health in London during the Olympic Games. At a discussion forum held at the London School of Hygiene & Tropical Medicine the Agency’s London Regional Director, Dr Brian McCloskey — also head of the World Health Organisation’s Collaborating Centre on Mass Gatherings — reassured reporter Sarah Maxwell that public health organisation during the Games is excellent.

MOSHI, TANZANIA—New insecticides to control mosquitoes — being tested in Tanzania — promise to overcome the biggest threat to malaria control in Africa: resistance to pyrethroid insecticides. Dr Richard Oxborough from the London School of Hygiene & Tropical Medicine explained to Sarah Maxwell how his group’s research evaluating new insecticides for mosquito nets and spraying inside houses, at the Kilimanjaro Christian Medical Centre in Moshi, Tanzania, is bringing hope for sustainable control of pyrethroid-resistant malaria-transmitting mosquitoes. The development of new insecticides for malaria vector control will help continue the decline of malaria in the region when combined with other malaria-control measures including new drugs, a vaccine and better diagnostic tests.

London School of Hygiene and Tropical Medicine Audio News: The New Decade Of Vaccines: Avoiding Public Distrust “Public trust and public confidence in vaccines are vital to keeping immunisation rates up and keeping the value of vaccines real,” according to Heidi Larson of the London School of Hygiene & Tropical Medicine who took part in: “The New Decade of Vaccines” a scientific meeting reflecting a series of articles about vaccination in The Lancet medical journal. She explains the importance of addressing public confidence issues to Sarah Maxwell.

LONDON—Part of the success of the Global Alliance for Vaccines and Immunisation (GAVI) talks held in London may have been the availability of new ways of funding vaccines to guarantee their affordability in low and middle-income countries. Dr James Hargreaves of the London School of Hygiene & Tropical Medicine tells Sarah Maxwell about “push” and “pull” techniques his group has been looking at to get the biggest “bang for the buck” in vaccine provision for the developing world.

LONDON—A new global network of scientists has been set up with the goal of helping all countries control infectious diseases. Instead of focussing on specific illnesses the Research Network For Health Systems And Infection — based at the London School of Hygiene & Tropical Medicine — concentrates specifically on improving health-care delivery systems. Mr Greg Reilly and Professor Anne Mills of the London School of Hygiene & Tropical Medicine join Professor David Heymann, Chair of the UK Health Protection Agency (and former Representative of the Director-General for Polio Eradication – World Health Organization) to tell Sarah Maxwell about the paramount importance of organising excellent health systems as a pre-requisite for establishing health for all.

LONDON—You can take your imagination for a free journey around the world of tropical medicine and public health in a matter of minutes by visiting the Archives of the London School of Hygiene and Tropical Medicine. Archivists Victoria Cranna and Emma Golding tell Sarah Maxwell how everybody can use this important resource of knowledge and original documents to conduct research — on line, or in person at the School in central London —on a wide range of health matters relating to circumstances near at hand or to situations in the most remote parts of the planet.

LONDON— At the London School of Hygiene and Tropical Medicine parties, a talk, and an exhibition on World Tuberculosis Day are commemorating the 24th of March 1882 when Robert Koch from Germany announced his discovery of the M.tuberculosis bacterium that causes tuberculosis. Sarah Maxwell hears from Ruth McNerney how the threat from TB still looms in many parts of the developing, and — surprisingly — developed world, and about the need for more research and better diagnostic tests.

LONDON/DELHI—India’s rapid economic growth should be harnessed to provide healthcare for all by the year 2020 according to doctors and health system leaders who met together at the London School of Hygiene and Tropical Medicine to launch a special “India Edition” of the medical journal The Lancet. Professor Vinod Paul from the All India Institute of Medical Sciences in Delhi told Sarah Maxwell how this should be achieved and why universal healthcare in areas such as reproductive and child health is a top priority.

To prevent AIDS it is essential to identify the factors driving the risk of infection in a particular community, rather than just applying a good — but un-researched — idea or a “one size fits all” approach to your strategy, according to Justin Parkhurst, of the London School of Hygiene and Tropical Medicine, who talked at the World AIDS Day symposium held at the School. He tells Sarah Maxwell about the need for tailoring the prevention strategy to match the underlying social and other factors driving HIV infection in any particular community, and he warns that this is context specific: and can differ greatly from one community to another.

The global battle against AIDS needs a ‘Robin Hood Tax’ to raise finance: rich countries need to shoulder the cost of fighting the pandemic in poor countries — as well as at home — in the interests of the whole planet. That’s according to Alvaro Bermejo, Executive Director of the International AIDS Alliance, who talked with Sarah Maxwell about his ideas during a symposium held at the London School of Hygiene and Tropical Medicine on World AIDS Day.

A special meeting of leading world experts on malaria — held at the London School of Hygiene & Tropical Medicine — heard that eradication of the disease is a viable global goal and that the challenge of using the effective known drugs and developing new ones can be met. Brian Greenwood, Professor of Tropical Medicine at the School, told Sarah Maxwell about recent developments which are bringing so much hope.

The meeting of world experts on malaria — held at the London School of Hygiene & Tropical Medicine — heard about fighting the global battle against malaria with well-organised health systems to deliver drug cures to those who need them and about the importance of communicating knowledge to the public. Sarah Maxwell hears a world-wide perspective from David Bell, Medical Officer of the WHO Global Malaria Programme; from Shunmay Yeung of the London School of Hygiene & Tropical Medicine on techniques being developed to help cope with the threat of drug resistance; and from Sarah Kline about:”Malaria No More UK” an organisation tackling malaria in Africa by raising funds and awareness in the United Kingdom and beyond.

An international group of scientists has found that one of the common types of malaria parasite — plasmodium ovale — is actually two completely different species, but living side by side in the same human communities. One of the researchers involved with the discovery (just published in the Journal of Infectious Disease), Colin Sutherland of the London School of Hygiene and Tropical Medicine, explains to Sarah Maxwell how this finding is not only interesting scientifically but could also help in the global fight against malaria.

Prof Giuseppe Saglio of the University of Turin and San Luigi Gonzaga Hospital in Italy on nilotinib as a new standard of care for chronic myeloid leukaemia. ASH President Nancy Berliner of Brigham & Women's Hospital adds her thoughts. Jorge Cortes of M. D. Anderson Cancer Center on three different ASH papers by his group looking at alternatives to standard imatinib in CML. Jane Apperley of Hammersmith Hospital and Imperial College London, reflects on these, and discusses strategies for dealing with imatinib resistance. OT Broadcast News Scientific Editor George Canellos of Dana-Farber Cancer Institute on what some were jokingly calling a re-run of World War II that took place in the Non-Hodgkin’s Lymphoma session: R-CHOP 14 vs R-CHOP 21 in elderly patients with diffuse large B-cell lymphoma. Andrzej Jakubowiak of the University of Michigan discusses a 4-drug regimen to treat newly diagnosed multiple myeloma....Ruben Niesvizky of Weill Cornell Medical College in New York City on the novel proteasome inhibitor carfilzomib, used in combination with lenalidomide and dexamethasone to treat relapsed or refractory multiple myeloma. OT interviewers: Peter Goodwin and Sarah Maxwell.

George Canellos on aggressive chemotherapy's failure to benefit patients with high-risk B-cell lymphoma. Massimo Martelli of University of Perugia on infused donor T-regulatory cells to prevent graft-vs-host-disease in patients with leukemia & lymphoma; comments from Armand Keating of the University of Toronto. Mathias Rummel of University Hospital in Germany on using bendamustine rather than CHOP combined with rituximab for treating indolent lymphomas—front-line. Commenting: Dr. Canellos and Richard Van Etten of Tufts University. Eduardo Rego of the University of Sao Paolo on his networking between North and South America to improve treatment of APL in developing countries. Adding their thoughts: Dr. Canellos and Richard Larson of the University of Chicago. OT Interviewers: Peter Goodwin and Sarah Maxwell.

At a briefing held simultaneously in London and Washington DC Richard Horton, Editor of The Lancet, Andy Haines, Director of the London School of Hygiene and Tropical Medicine, Anil Markandya from the Basque Centre for Climate Change in Bilbao, Spain, and Paul Wilkinson, James Woodcock and Alan Dangour from the London School tell Sarah Maxwell and Peter Goodwin about their findings, just published in a special edition of the Lancet, on the consequences to human health of mitigating the effects of greenhouse gas emissions. In agriculture and food, urban transportation, electricity generation and home energy use the Lancet data showed large positive effects on human health over the next few decades if we choose the right strategies to reduce greenhouse gas emissions.

London School of Hygiene and Tropical Medicine Audio News: Malaria In The Gambia: Insect Screens Cut Mosquito Numbers And Anaemia By Half In research involving hundreds of houses in the town of Farafenni in The Gambia insect screens covering windows and openings were found to cut the numbers of mosquitoes indoors by 59 per cent. In addition the rates of childhood anaemia related to malaria in the houses being screened were halved in comparison to other homes not screened, according to findings recently published in the journal: The Lancet. Professor Steve Lindsay from the London School of Hygiene and Tropical Medicine discussed the role of such screens for malaria control with Sarah Maxwell.

Peter Goodwin and Sarah Maxwell take part in the discussions held in London on the controversial role of the corporate sector in tackling the looming threat to global health of obesity around the world. They also hear how drastic economic changes in the former Soviet Union have caused an increase in mortality—largely driven by alcohol; about the unexpected down-side free trade can have in worsening health—rather than improving it—in some situations; about the health benefits to the world of the new American president, and how good national health can boost the economy just as the other way around. Controversies in Global Health—What role should the corporate sector play in tackling the global obesity pandemic? Philip James, Director, International Obesity Task Force Derek Yach, Director, Pepsico Global Health Policy Andy Haines, Director, London School of Hygiene and Tropical Medicine Patti Rundall, Policy Director, Baby Milk Action, Cambridge Drastic Economic Changes Increase Mortality Martin McKee, Director, European Centre for Health Of Societies in Transition, London School of Hygiene and Tropical Medicine. Free Trade Brings Health Benefits? —Think Again! Richard Smith, Professor of Health System Economics, London School of Hygiene and Tropical Medicine Kelley Lee, London School of Hygiene and Tropical Medicine Obama And Global Health? National Health and Wealth—Reciprocal Relationship Martin McKee, London School of Hygiene and Tropical Medicine

Oncology Times Broadcast News with the Audio Journal of Oncology Scientific Editors: George Canellos, Dana-Farber Cancer Institute, Boston Gordon McVie, European Institute of Oncology, Milan Pat Price, Christie Hospital, Manchester Gianni Bonadonna, Istituto Nazionale Tumori, Milan REPORTING FROM: National Cancer Research Institute Cancer Conference, October 5-8, 2008, Birmingham, England American Society of Clinical Oncology Annual Meeting, May 30-June 3, 2008, Chicago, Illinois, Perspectives In Lung Cancer 9th European Congress, March 14-15, Torino, Italy Sarah Maxwell and Peter Goodwin report on evidence that combining monoclonal antibodies with chemotherapy can extend life among patients with advanced non-small-cell lung cancer. Robert Pirker from the Medical University of Vienna tells Sarah Maxwell about his group's findings in the FLEX study using the epidermal growth factor receptor (EGF-R) inhibitor cetuximab; Christian Manegold from Heidelberg Universit, Manheim gives Peter Goodwin data on the vascular endothelial growth factor (VEGF-R) bevacizumab; while Giorgio Scagliotti from Torino University, Nick Thatcher from the Christie Hospital, Manchester and Howard Sandler from the University of Michigan, Ann Arbor discuss the clinical implications of these approaches to using molecular targeting to improve outcomes in advanced non-small-cell lung cancer. Michel Coleman from the London School of Hygiene and Tropical Medicine tells Peter Goodwin about the findings of the CONCORD study looking at international differences between survival rates for breast, prostate and colorectal cancers.

LSHTM Audio News - January 17th, 2008 With one child in three killed by it, childhood and maternal undernutrition are discussed in a special series of articles in the Lancet. Sarah Maxwell spoke with Zulfiqar Bhutta about his group's massive study, and in particular about the risks of not breastfeeding optimally. The interval from conception to age 24 months has been named as the critical period for child nutrition, with big health effects in adult life. Caroline Fall spoke with Karen Regester about the evidence her group has published in The Lancet on five key studies on maternal and infant nutrition. Simon Cousens talked with Peter Goodwin about a new study of interventions, including promoting breast feeding, and vitamin supplements for combating maternal and child undernutrition. Bruce Cogill gave Peter Goodwin his assessment of the chances of success in the global battle to save the lives of a third of the world's children. Lancet Editor, Richard Horton, explained the importance of these new findings to Sarah Maxwell.

Audio Journal of Oncology, December 10th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Oblimersen Extends Survival in Chronic Lymphocytic Leukemia SUSAN O'BRIEN, MD Anderson Cancer Center, Houston REFERENCE: ASH 2007 For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology meeting in Atlanta. Sarah Maxwell reports.

Audio Journal of Oncology, December 10th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta Ibritumomab Provides Benefit in Patients with Follicular Lymphoma ANTON HAGENBEEK, University Medical Centre Utrecht REFERENCE: ABSTRACT 643, ASH 2007 For patients with advanced-stage follicular non-Hodgkin’s lymphoma, ibritumomab tiuxetan seems to prolong progression free survival by two years with favourable toxicity. Sarah Maxwell spoke to study author Anton Hagenbeek at the ASH meeting in Atlanta while George Canellos provided comment.

Audio Journal of Oncology, December 8th, 2007 Reporting from: American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta New Drug AMG 531 Effective in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura TERRY GERNSHEIMER, University of Washington Medical Center, Seattle REFERENCE: ABSTRACT 2, ASH 2007 An investigational drug AMG 531 has increased and sustained platelet counts in splenectomized patients with chronic immune thrombocytopenia purpura or ITP. This was in a placebo controlled phase III trial that randomized patients to receive either the novel agent or a placebo. The new drug increased platelet counts and was also well tolerated. Sarah Maxwell spoke to study author Terry Gernsheimer from the University of Washington during the American Society of Hematology meeting in Atlanta.

Audio Journal of Cardiovascular Medicine, November 6th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida Protective Cardiovascular Benefit for Women on HRT For Natural Menopause GEORGE SOPKO, National Heart, Lung And Blood Institute, Bethesda, Maryland COMMENT: JENNIFER MIERES, New York University REFERENCE: Abstract 3771 A new study presented to the American Heart Association meeting found women taking hormone replacement therapy since the menopause had a protective cardiovascular benefit. This was greater the earlier HRT was initiated and the women who took HRT had lower rates of coronary artery disease. Chief study author George Sopko spoke with Sarah Maxwell at the Orlando meeting.

Audio Journal of Cardiovascular Medicine, November 6th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results PHILIP BARTER, Heart Research Institute, Sydney, Australia COMMENT: GORDON TOMASELLI, Johns Hopkins University, Baltmimore REFERENCE: Late Breaking Clinical Trials Session 2 A randomized double-blind study involving over 15,000 patients at high cardiovascular risk which looked at the new agent torcetrapib (an inhibitor of cholesteryl ester transfer protein, CETP) resulted in higher mortality in the experimental arm. The study compared torcetrapib plus atorvastatin with atorvatstin alone. Inhibition of CETP increases HDL levels and reduces LDL levels and should combat atherosclerosis. Sarah Maxwell spoke with Philip Barter who presented data on the ILLUMINATE trial at the American Heart Association meeting in Orlando.

Audio Journal of Cardiovascular Medicine, November 6th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida TAXUS DES Trials Results: How Long Should Thienopyridine Be Used After Drug Eluting Stent? GREGG STONE, Columbia University, New York REFERENCE: Abstract 2357 New light has been thrown on the use of thienopyridine therapy after percutaneous intervention using drug-eluting stents. Gregg Stone presented data from the TAXUS DES trials which looked at patients surviving more than a year after receiving either paclitaxel-eluting or bare metal stents. After his talk at the American Heart Association he discussed his findings with Sarah Maxwell.

Audio Journal of Cardiovascular Medicine, November 6th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida Eptifibatide as Effective as Abciximab in Primary PCI for Acute ST Elevation Myocardial Infarction: EVA-AMI Study UWE ZEYMER, Herzzentrum Ludwigshafen, Germany REFERENCE: Late Breaking Clinical Trials Session 1 The glycoprotein 2B 3A antagonist eptifibatide has performed as well as standard abciximab therapy in patients receiving primary angioplasty for acute myocardial infarction. So according to Uwe Zeymer who presented findings on this it can be used in this setting just as it is already being used in elective PCI. Sarah Maxwell interviewed Dr Zeymer at the Orlando conference.

Audio Journal of Cardiovascular Medicine, November 5th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida TRITON-TIMI 38 Prasugrel Or Clopidogrel In Percutaneous Intevention? GORDON TOMASELLI, Johns Hopkins University, Baltimore COMMENT: DANIEL JONES, President, American Heart Association, University of Mississippi, Jackson REFERENCE: Late Breaking Clinical Trials 1, AHA 2007 A potential new option for patients with acute coronary syndromes receiving coronary intervention has emerged following a report on the comparison of prasugrel, a new anti-platelet agent, with clopidogrel. Elliott Antman from Brigham and Women’s Hospital in Boston gave the American Heart Association his findings and recommendations about when and in which patients prasugrel might be favored. Gordon Tomaselli discussed the findings with Sarah Maxwell.

Audio Journal of Cardiovascular Medicine, November 5th, 2007 Reporting from: American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI LAURA MAURI, Brigham and Woman’s Hospital, Boston Massachusetts COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester, Minnesota REFERENCE: Late Breaking Special Session, AHA 2007 The largest study to date looking at long-term outcomes of bare metal stents as compared with drug eluting stents in patients who have undergone PCI was presented to the American Heart Association annual meeting. There was no increased mortality for patients who received drug eluting stents in a Massachussets based population. Sarah Maxwell spoke with investigator to Laura Mauri at the Orlando meeting.

Wednesday, September 5th - European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria 1. Better Criteria For Cardiac Resynchronisation Needed in Heart Failure: PROSPECT Trial Results STEFANO GHIO, San Matteo University Hospital, Italy COMMENT: CECILIA LINDE, Karolinska University Hospital, Stockholm REFERENCE: Hotline III, 3222 page 315 The standard echocardiographic criteria for selecting patients to receive cardiac resynchronisation are not adequate according to Stefano Ghio. During the ESC Congress in Vienna he presented results from the PROSPECT trial and afterwards he talked with Sarah Maxwell. Cecilia Linde gave Nicola Solomon her comments on the findings. 2. Selective Invasive Treatment Best for Women with Non-ST Elevation Acute Coronary Syndromes EVA SWAHN, University Hospital Linköping, Sweden COMMENT: ECKART FLECK, Deutsches Herzzentrum, Berlin REFERENCE: HOTLINE II, Monday 8am Women who undergo selective invasive treatment for non-ST elevation acute coronary syndromes do better than those who receive routine early invasive treatment. This is according to the OASIS 5 study from Sweden that randomised women to either of the two approaches. The findings suggest that females with non-ST elevation ACS should be approached differently from their male counterparts. Sarah Maxwell interviewed OASIS investigator Eva Swahn at the ESC meeting in Vienna. Eckart Fleck of the Deutsches Herzzentrum in Berlin gave his comments on her comments to Derek Thorne. 3Patients with High Restenosis Risk Benefit More from Drug Eluting Stents RAUL MORENO, University Hospital La Paz, Madrid REFERENCE: Abstract 3103 Results from a large meta analysis suggest that drug eluting stents have a greater benefit when the risk of restenosis increases. This could affect the “off label” use of these stents. Raul Moreno, of the University Hospital La Paz, Madrid, discussed his findings with Derek Thorne.

Tuesday, September 4th - European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria 1. Drug Eluting Stents: Higher Late Mortality in STEMI Patients Than Bare Metal: GRACE Registry Findings GABRIEL STEG, Hôpital Bichat, Paris COMMENT: FREEK VERHEUGT, Radboud University Nijmegen Medical Centre, Nijmegen REFERENCE: Hotline III, number 709 The GRACE registry looking at over 60 000 patients with ST elevation myocardial infarction has shown that patients live longer if they receive bare metal stents than if they get drug eluting stents. Gabriel Steg presented these latest data at the ESC meeting in Vienna. Sarah Maxwell discussed the findings with him. 2. Looking for Atherosclerosis in the Legs Could Save Lives CURT DIEHM, University of Heidelberg COMMENT: FREEK VERHEUGT, Radboud University Nijmegen Medical Centre, Nijmegen Peripheral arterial disease (PAD) can be diagnosed easily by a test using the ankle brachial index (ABI) and its presence can indicate a high risk of myocardial infarction. Curt Diehm explained his findings to Derek Thorne, while Peter Goodwin got expert comment from Freek Verheugt. 2. Heart Attacks Drop After Smoking Ban in Ireland EDMOND CRONIN, Cork University Hospital REFERENCE: Abstract 3506, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria Study data that support banning smoking in public places were unveiled at the ESC congress by a team from Ireland. After the smoking ban in 2004, admissions for acute coronary syndromes dropped, and lead author Edmond Cronin explained the significance of his findings to Derek Thorne.

Monday, September 3rd - European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria 1. Chronic Stable Angina: Should ESC Guidelines on Clopidogrel as Pre-Treatment to Planned Coronary Angiography be Changed? PETR WIDIMSKY, Charles University, Prague COMMENT: ECKART FLECK, Deutsches Herzzentrum Berlin REFERENCE: Hot Line II Monday 3rd Sept The ESC guideline suggesting all patients with chronic stable angina having coronary angiography should have clopidogrel pre-treatment is now being questioned following findings of the PRAGUE-8 Study, which randomized patients to receive the anti-platelet agent either non selectively before angiography, or selectively after angiography in those considered to need PCI. The PRAGUE investigators concluded that the ESC guideline was unjustified for the treatment of elective angiography in chronic stable angina, and that the previous practice of selective administration of clopidogrel should be resumed. Nicola Solomon talked with Petr Widimsky at the ESC Congress in Vienna. Derek Thorne heard comments on the findings from Eckart Fleck. 2. Enoxaparin Superior to Unfractionated Heparin for STEMI at 12 months Follow Up: ExTRACT-TIMI 25 Trial DAVID MORROW, Brigham and Women’s Hospital, Boston REFERENCE: 1027, Clinical Trial Update I Further data to support the use of enoxaparin has come out of the latest update from the ExTRACT-TIMI 25 study. It shows at 12 months follow up, that the benefits of enoxaparin are durable and still superior to unfractionated heparin for patients with ST elevation myocardial infarction undergoing fibrinolytic therapy. Sarah Maxwell interviewed David Morrow at the Vienna meeting. 3. Drug Eluting Stent Shows Great Benefit in Chronic Total Occlusions GERALD WERNER, Klinikum Darmstadt, Germany REFERENCE: Abstract 925 The ESC congress in Vienna heard that drug eluting stents are highly effective in chronically occluded arteries, when compared with bare metal stents. Derek Thorne got more on this German study from Gerald Werner, of Klinikum Darmstadt in Germany.

Sunday, September 2nd - European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria 1. Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study REFERENCE: Abstract 312 Hot Line 1 Sunday STEPHEN MACMAHON, The George Institute, University of Sydney COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester MN The randomised placebo controlled ADVANCE study of 11000 patients with diabetes has demonstrated that a combination of the ACE inhibitor, perindopril, with the diuretic indapamide can lower blood pressure and mortality. The investigators saw an impact even in patients who did not have high blood pressure. Lead study author Stephen MacMahon said this approach should be included in current practise guidelines. Sarah Maxwell spoke with him at the meeting in Vienna. Commented on Stephen McMahon's presentation of the ADVANCE study looking at the use of perindopril plus indapamide among patients with diabetes: a study with 11 000 patients divided between active and placebo in which a 14 per cent improvement in all-cause mortality, an 18 per cent reduction of cardiovascular deaths, was achieved together with reductions of the incidence of both renal and coronary disease. 2. Lifestyle and Heart Disease in Europe: A Growing Problem REFERENCE: Abstract 316 DAVID WOOD, Charing Cross Hospital, London Among 8000 coronary patients in 9 European countries, smoking prevalence hasn’t changed over the last 12 years, and obesity is going up – that’s according to the combined EUROASPIRE surveys, which were presented at the ESC congress. Derek Thorne got more from David Wood, of Charing Cross Hospital in London. 3. Drug Eluting Stents, Bare Metal Stents: No Survival Difference REFERENCE: Hot Line 1 Sunday 11:00 2 Sept/ESC Congress 2007 Vienna 1-5 September STEFAN JAMES, Uppsala Clinical Research Centre, Sweden COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester MN Another year’s results of the long term outcome of using drug-eluting stents as compared with bare-metal stents from Sweden reveal that there is no longer an increased risk of late mortality when using drug-eluting stents according to Stefan James of Uppsala Clinical Research Centre. He suggested that improvements in technique have helped reduce the risk of death or myocardial infarction associated with using drug-eluting stents nevertheless the risk of blood clots still remains. Overall survival of patients was found to be the similar for both categories of stent.

Audio Journal of Medicine, August 2nd 2007 Reporting from: 23rd Annual Conference of the European Society of Human Reproduction and Embryology, 1-4 July 2007, Lyon, France Cortical Grafting Or Intact Ovary Transplantation for Preserving Fertility? REFERENCE: O-149 SHERMAN SILBER, St Luke's Hospital, St Louis MO A study from Missouri has shown that transplanting intact ovaries using microvascular surgical techniques is superior in the long term for restoring or preserving fertility to the simpler technique known as cortical grafting. Sarah Maxwell heard about the findings from Sherman Silber during the fertility conference held in Lyon.

Audio Journal of Medicine, August 2nd 2007 Reporting from: 23rd Annual Conference of the European Society of Human Reproduction and Embryology, 1-4 July 2007, Lyon, France Lapraroscopic Ovarian Diathermy Or Clomifene as First Line Treatment for Polycystic Ovarian Syndrome? REFERENCE: O-148 SAAD AMER, The Derby Medical School, Nottingham University More reassurance about the use of clomifene for treating anovulatory women with polycystic ovarian syndrome has emerged from a randomised study from Nottingham reported to the fertility conference held in Lyon. Laparoscopic ovarian diathermy, normally used as second line treatment (after clomifene), was found to be equivalent for inducing ovulation and pregnancy in a study with over sixty women. But Saad Amer explained to Sarah Maxwell why he still favours clomifene.

Audio Journal of Medicine, August 2nd 2007 Reporting from: 23rd Annual Conference of the European Society of Human Reproduction and Embryology, 1-4 July 2007, Lyon, France Single Embryo Transfer: Just as High Live Birth Rates as Double Transfer, But Without Risks REFERENCE: O-004 KERSTI LUNDIN, Sahlgrenska University Hospital, Göteborg, Sweden The same birth rates following in-vitro fertilisation can be achieved with single embryo transfer as with double transfer, according to the findings of a study from Sweden. A retrospective investigation looked at whether multiple births, and other risk factors associated with double embryo transfer, can be avoided when single transfer is used whilst still achieving the same live delivery rates. Sarah Maxwell talked with study author Kersti Lundin during the European fertility conference in Lyon.

Audio Journal of Medicine, August 2nd 2007 Reporting from: 23RD Annual Conference of the European Society of Human Reproduction and Embryology, 1-4 July 2007, Lyon, France GnRH Antagonist Protects of Ovarian Function During Chemotherapy REFERENCE: O-144 KATE STERN, Royal Women's Hospital, Melbourne A potential new way of preserving ovarian function during chemotherapy for cancer could be treatment with an antagonist of gonadotropin-releasing hormone: GnRH. A pilot study from Melbourne looked at 18 young women with cancer or auto immune disease due to receive cyclophosphamide therapy. Sarah Maxwell spoke with Kate Stern and heard more about the study.

Audio Journal of Medicine Reporting from European Society of Human Reproduction and Embryology (ESHRE) 23rd Annual Meeting, Lyon, July 1-4, 2007 1. Eggs From Young Patients Before Chemotherapy: New Hope for Future Fertility REFERENCE: ABSTRACT O-107 Ariel Revel, Hadassah University Hospital, Jerusalem Harvesting eggs from young girls before they undergo aggressive chemotherapy can now be done to give the hope of pregnancy in the future, according to fertility experts from Jerusalem reporting to the European conference on fertility being held in Lyon. The investigators have obtained oocytes from girls as young as five years. Lead author Ariel Revel talked about his group's findings with Sarah Maxwell. 2. First Baby Born From Thawed, Frozen, In-Vitro Matured Oocytes REFERENCE: ABSTRACT Oral 018 Hananel Holzer, McGill University, Montreal The results of a study that has produced the first live birth by maturing oocytes in vitro which have been collected from unstimulated ovaries, freezing them, and subsequently thawing them for fertilization were presented to the ESHRE meeting in Lyon. This is the first time oocytes collected without hormonal stimulation have resulted in pregnancies. For some women potentially facing sterility, such as those with breast cancer who do not have time for hormonal stimulation, this technique provides the hope of pregnancy which could otherwise be denied. Sarah Maxwell interviewed Hananel Holzer about the findings. 3. Ovarian Stimulation: Menotrophin Gives More Live Births than Follicle-Stimulating Hormone for Assisted Reproduction REFERENCE: ABSTRACT Oral 098 Masoud Afnan, Birmingham Women's Hospital Of two types of gonadotrophins currently used for ovarian stimulation in assisted reproduction one has now clearly demonstrated superiority in a meta-analysis presenteted to the fertility conference in Lyon. Human menotrophin (hGH) gave more live births than recombinant follicle-stimulating hormone (rFSH) whether reproduction was by in-vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). Peter Goodwin talked with Masoud Afnan from Birmingham after his presentation of the study which he co-authored with Madelon van Wely and Julko van der Veen. 4. Single Embryo Transfer Recommended For Most Patients Receiving Donated Oocytes REFERENCE: ABSTRACT O-007 Viveca Söderström-Anttila, Väestoliitto Fertility Clinics, Helsinki When oocytes are donated to achieve a pregnancy, single embryo transfer should generally be recommended over double transfer, according to the findings of a study from Helsinki. Sarah Maxwell discussed the data with Viveka Söderström.

Audio Journal of Cardiovascular Medicine Reporting from ACC 2007 Reduced Mortality and Repeat MI with Enoxaparin for Patients with ST Elevation Myocardial Infarction HARVEY WHITE, Auckland City Hospital, New Zealand REFERENCE: European Heart Journal Advanced On-Line Publication April 24th, 2007 Enoxaparin could be the new standard anti-thrombotic therapy for patients receiving fibrinolysis for ST elevation myocardial infarction. This finding is from the double-blind EXTRACT-TIMI 25 Trial which compared the low molecular weight heparin with unfractionated heparin and saw a consistent treatment superiority from enoxaparin with a reduction in repeat myocardial infarction and mortality. Sarah Maxwell spoke with the principal investigator Harvey White at the Auckland City Hospital in New Zealand.

Audio Journal of Cardiovascular Medicine Reporting from ACC 2007 Fewer Major Bleeding Events with Bivalirudin For Patients with Acute Coronary Syndromes: The ACUITY Study REFERENCE: ACUITY Trial, ACC.07 Scientific Session and i2 Innovations Summit. Presentation Number: 2414-5 Patients with acute coronary syndromes who take bivalirudin have fewer major bleeding events and a lower incidence of late stent thrombosis’ compared with those who receive standard heparin therapy. This is the finding of one year results from the ACUITY Study announced by Gregg Stone of Columbia University, New York during the American College of Cardiology annual meeting that took place in New Orleans. Sarah Maxwell asked Harvey White at the Auckland City Hospital in New Zealand to comment about the ACUITY investigation.

Audio Journal of Global Health Issues Folic Acid Supplement Improves Cognitive Function in Older Adults: FACIT Trial REFERENCE: Lancet 2007;369:208 JANE DURGA, Nestlé Research Centre, Lausanne A trial that randomised older adults to receive a folic acid supplement or placebo has shown that folic acid can significantly improve cognitive performance in older individuals. Jane Durga in Lausanne told Sarah Maxwell about the study findings and the hopes these may hold out.

Audio Journal of Global Health Issues The Genetics of Obesity: Genetic Mutation, Possible Marker for Obesity? REFERENCE: N Engl J Med 2007;356:237-47 SADAF FAROOQI, Addenbrooke’s Hospital, Cambridge UK Gene defects and mutations could be markers for early onset obesity. This is according to a study published in the New England Journal of Medicine which concludes that the leptin receptor should be further explored as a cause of obesity, along with other genetic factors emerging from a multinational study called: the Genetics of Obesity Study. Sarah Maxwell heard the latest from Sadaf Farooqi in Cambridge, England.